Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09AA01	APO-CAPTO	G	Captopril - 25mg	25mg	Tablet, scored	1,132,859 L.L
C09AA01	APO-CAPTO	G	Captopril - 50mg	50mg	Tablet, scored	1,752,371 L.L
N03AF01	APO-CARBAMAZEPINE	G	Carbamazepine - 200mg	200mg	Tablet	727,019 L.L
B01AC04	APO-CLOPIDOGREL	G	Clopidogrel (Bisulfate), - 75mg	75mg	Tablet	911,125 L.L
L01EA02	APO-DASATINIB	G	Dasatinib - 70mg	70mg	Tablet	71,323,688 L.L
L01EA02	APO-DASATINIB	G	Dasatinib - 50mg	50mg	Tablet	71,323,688 L.L
L01EA02	APO-DASATINIB	G	Dasatinib - 20mg	20mg	Tablet	57,771,855 L.L
C08DB01	APO-DILTIAZ	G	Diltiazem HCl - 60mg	60mg	Tablet	545,600 L.L
J05AF10	APO-ENTECAVIR	G	Entecavir - 0.5mg	0.5mg	Tablet	28,943,287 L.L
L01EB02	APO-ERLOTINIB	G	Erlotinib (HCl) - 100mg	100mg	Tablet	79,672,726 L.L
L01EB02	APO-ERLOTINIB	G	Erlotinib (HCl) - 150mg	150mg	Tablet	91,523,229 L.L
N06AB10	APO-ESCITALOPRAM	G	Escitalopram (oxalate) - 10mg	10mg	Tablet	565,758 L.L
N06AB10	APO-ESCITALOPRAM	G	Escitalopram (oxalate) - 20mg	20mg	Tablet	1,087,169 L.L
C03CA01	APO-FUROSEMIDE	G	Furosemide - 40mg	40mg	Tablet, scored	862,747 L.L
N03AX12	APO-GABAPENTIN	G	Gabapentin - 300mg	300mg	Capsule	2,527,768 L.L
L01EB01	APO-GEFITINIB	G	Gefitinib - 250mg	250mg	Tablet	87,345,820 L.L
L01EA01	APO-IMATINIB	G	Imatinib - 100mg	100mg	Tablet	18,838,684 L.L
L02BG04	APO-LETROZOLE	G	Letrozole - 2.5mg	2.5mg	Tablet	1,962,010 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 5mg	5mg	Tablet, orally disintegrating	1,463,444 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 10mg	10mg	Tablet, orally disintegrating	2,422,948 L.L
A04AA01	APO-ONDANSETRON	G	Ondansetron - 8mg	8mg	Tablet	1,491,665 L.L
N06AB05	APO-PAROXETINE	G	Paroxetine (HCl) - 20mg	20mg	Tablet	983,693 L.L
C10AA03	APO-PRAVASTATIN	G	Pravastatin Sodium - 40mg	40mg	Tablet	958,160 L.L
C10AA03	APO-PRAVASTATIN	G	Pravastatin Sodium - 20mg	20mg	Tablet	775,397 L.L
C07AA05	APO-PROPRANOLOL	G	Propranolol HCl - 10mg	10mg	Tablet, scored	280,863 L.L
C07AA05	APO-PROPRANOLOL	G	Propranolol HCl - 40mg	40mg	Tablet, scored	356,118 L.L
C09AA05	APO-RAMIPRIL	G	Ramipril - 2.5mg	2.5mg	Capsule	463,626 L.L
C09AA05	APO-RAMIPRIL	G	Ramipril - 5mg	5mg	Capsule	794,211 L.L
C09AA05	APO-RAMIPRIL	G	Ramipril - 10mg	10mg	Capsule	1,178,550 L.L
M05BA07	APO-RISEDRONATE	G	Risedronate sodium - 150mg	150mg	Tablet	1,034,759 L.L

...

187